Qi Bin Liang
Chief Tech/Sci/R&D Officer at GENOR BIOPHARMA HOLDINGS LIMITED
Profile
Qi Bin Liang is the founder of CMAB BioPharma (Suzhou) Inc. He is currently working as the Chief Technology Officer at Genor Biopharma Holdings Ltd.
He completed his graduate degree from the University of Idaho and his undergraduate degree from East China University of Science & Technology.
Qi Bin Liang active positions
| Companies | Position | Start |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 01/10/2021 |
CMAB BioPharma (Suzhou) Inc.
 CMAB BioPharma (Suzhou) Inc. Miscellaneous Commercial ServicesCommercial Services CMAB BioPharma (Suzhou) Inc. develops and manufactures biological products. Its services include process development, GMP manufacturing, aseptic drug and quality development. The company was founded by Qibin Liang in June 2017 and is headquartered in Suzhou, China. | Founder | - |
Training of Qi Bin Liang
| University of Idaho | Graduate Degree |
| East China University of Science & Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
CMAB BioPharma (Suzhou) Inc.
CMAB BioPharma (Suzhou) Inc. Miscellaneous Commercial ServicesCommercial Services CMAB BioPharma (Suzhou) Inc. develops and manufactures biological products. Its services include process development, GMP manufacturing, aseptic drug and quality development. The company was founded by Qibin Liang in June 2017 and is headquartered in Suzhou, China. | Commercial Services |
- Stock Market
- Insiders
- Qi Bin Liang
